Published in Neurology on September 04, 2013
Clinical Trial Ceftriaxone in Subjects With ALS | NCT00349622
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation (2015) 0.75
Outcome measures in amyotrophic lateral sclerosis clinical trials. Clin Investig (Lond) (2014) 0.75
Characteristics of participants consenting versus declining follow-up for up to 10 years in a randomized clinical trial. Clin Trials (2015) 0.75
Behavioral and Social Sciences at the National Institutes of Health: adoption of research findings in health research and practice as a scientific priority. Transl Behav Med (2017) 0.75
The price of innovation: new estimates of drug development costs. J Health Econ (2003) 23.43
Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med (2002) 11.14
A systematic review of the associations between dose regimens and medication compliance. Clin Ther (2001) 9.23
Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol (2006) 8.64
Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials (1981) 6.06
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. J Clin Oncol (2006) 4.91
Costs and benefits of the national cancer institute central institutional review board. J Clin Oncol (2009) 4.39
Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol (2006) 3.39
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med (2011) 3.16
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2010) 2.91
Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group. Clin Cancer Res (2008) 2.89
Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord (2010) 1.50
Challenges of recruitment and retention in multisite clinical research. Cancer Nurs (2003) 1.40
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther (2010) 1.39
Low patient enrollment sites in multicenter randomized clinical trials of cerebrovascular diseases: associated factors and impact on trial outcomes. J Stroke Cerebrovasc Dis (2010) 1.25
Local institutional review board (IRB) review of a multicenter trial: local costs without local context. Ann Neurol (2010) 1.23
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology (2005) 1.21
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis. Muscle Nerve (2008) 1.04
Maintaining adherence and retention in dementia prevention trials. Neurology (2006) 0.94
Understanding recruitment and retention in neurological research. J Neurosci Nurs (2010) 0.91
Recruitment and retention in clinical trials of the elderly. Int Rev Neurobiol (2007) 0.90
NIA-funded Alzheimer centers are more efficient than commercial clinical recruitment sites for conducting secondary prevention trials of dementia. Alzheimer Dis Assoc Disord (2010) 0.85
Trial networks move beyond single-disease strategies. Nat Med (2011) 0.84
Failure to report protocol violations in clinical trials: a threat to internal validity? Trials (2011) 0.83
Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis. Expert Opin Emerg Drugs (2007) 0.80
Proposed BioRepository platform solution for the ALS research community. Amyotroph Lateral Scler (2010) 0.80
The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67
Global histone modification patterns predict risk of prostate cancer recurrence. Nature (2005) 7.03
A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62
Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 5.63
PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem (2007) 4.79
GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform (2004) 4.57
Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science (2011) 4.46
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A (2007) 4.20
Frontiers of biomedical text mining: current progress. Brief Bioinform (2007) 4.11
Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol (2002) 3.14
Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences. J Clin Oncol (2010) 3.09
Complications of beta-thalassemia major in North America. Blood (2004) 2.97
Hid, Rpr and Grim negatively regulate DIAP1 levels through distinct mechanisms. Nat Cell Biol (2002) 2.95
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation (2007) 2.88
Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve (2011) 2.85
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation (2003) 2.82
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science (2009) 2.76
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest (2012) 2.67
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1. Blood (2010) 2.61
CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation (2006) 2.51
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol (2013) 2.43
Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood (2006) 2.42
Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer (2007) 2.38
Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials. Clin Neurophysiol (2007) 2.36
Global levels of histone modifications predict prognosis in different cancers. Am J Pathol (2009) 2.28
Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat Med (2005) 2.24
Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood (2002) 2.02
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A (2002) 2.00
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J Neurochem (2005) 1.91
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem (2005) 1.91
Mouse model for human arginase deficiency. Mol Cell Biol (2002) 1.88
Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation (2003) 1.87
Acupuncture for upper-extremity rehabilitation in chronic stroke: a randomized sham-controlled study. Arch Phys Med Rehabil (2005) 1.86
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest (2003) 1.84
Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. Mitochondrion (2010) 1.80
Antiviral effect of the mammalian translation initiation factor 2alpha kinase GCN2 against RNA viruses. EMBO J (2006) 1.79
Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes. Arch Surg (2011) 1.78
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76
Automatically classifying sentences in full-text biomedical articles into Introduction, Methods, Results and Discussion. Bioinformatics (2009) 1.74
Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica (2007) 1.74
Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol (2009) 1.73
The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.68
An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcohol Clin Exp Res (2005) 1.68
Arginases I and II: do their functions overlap? Mol Genet Metab (2004) 1.67
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A (2006) 1.66
Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment arms. J Clin Oncol (2010) 1.66
Increased incidence of deep venous thrombosis in ALS. Neurology (2007) 1.64
New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci (2007) 1.62
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res (2007) 1.61
Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res (2009) 1.61
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol (2005) 1.60
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia. Blood (2012) 1.58
Multiple apoptotic caspase cascades are required in nonapoptotic roles for Drosophila spermatid individualization. PLoS Biol (2003) 1.57
AskHERMES: An online question answering system for complex clinical questions. J Biomed Inform (2011) 1.57
Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols. Blood (2009) 1.56
Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med (2006) 1.56
Interaction of the onset of spring and elevated atmospheric CO2 on ragweed (Ambrosia artemisiifolia L.) pollen production. Environ Health Perspect (2006) 1.54
Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents. Haematologica (2012) 1.53
Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome. Europace (2010) 1.53
Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res (2009) 1.52
Relationships of sleep duration with sleep disturbances, basic socio-demographic factors, and BMI in Chinese people. Sleep Med (2009) 1.51
Regulation of mitochondrial oxidative phosphorylation through cell signaling. Biochim Biophys Acta (2007) 1.51
Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res (2004) 1.51
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol (2012) 1.51
Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression. Mol Cell Biol (2007) 1.50
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103. Cytotherapy (2010) 1.50
Lancet: a high precision medication event extraction system for clinical text. J Am Med Inform Assoc (2010) 1.49
Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci (2010) 1.48
Complete genome sequence of bacteriophage T5. Virology (2005) 1.48
Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation (2003) 1.47
Is it too soon for mesenchymal stem cell trials in people with ALS? Amyotroph Lateral Scler (2008) 1.46
Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron (2010) 1.45
Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice. Leuk Res (2004) 1.45
Role of individual basal ganglia nuclei in force amplitude generation. J Neurophysiol (2007) 1.44
Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv (2013) 1.43
Neuromodulation of the cingulum for neuropathic pain after spinal cord injury. Case report. J Neurosurg (2007) 1.42
Heat stress-induced response of the proteomes of leaves from Salvia splendens Vista and King. Proteome Sci (2013) 1.41
TARPs differentially decorate AMPA receptors to specify neuropharmacology. Trends Neurosci (2010) 1.39
Association of genetic polymorphisms in the fibrinogen and platelet glycoprotein genes with unstable angina in Chinese patients. Clin Cardiol (2004) 1.39
FigSum: automatically generating structured text summaries for figures in biomedical literature. AMIA Annu Symp Proc (2009) 1.38
A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci U S A (2002) 1.38
Parameter uncertainty analysis of non-point source pollution from different land use types. Sci Total Environ (2009) 1.37
Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma. Cancer Res (2007) 1.37
Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells (2008) 1.34
Hierarchical modularity of nested bow-ties in metabolic networks. BMC Bioinformatics (2006) 1.33
Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia. J Immunol (2008) 1.32
Metabolomic analysis and signatures in motor neuron disease. Metabolomics (2005) 1.31
TNF/TNFR signal transduction pathway-mediated anti-apoptosis and anti-inflammatory effects of sodium ferulate on IL-1β-induced rat osteoarthritis chondrocytes in vitro. Arthritis Res Ther (2012) 1.30
A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy. Brachytherapy (2013) 1.29
Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension (2011) 1.29
The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J (2004) 1.29
High frequency deep brain stimulation attenuates subthalamic and cortical rhythms in Parkinson's disease. Front Hum Neurosci (2012) 1.29
Exploring supervised and unsupervised methods to detect topics in biomedical text. BMC Bioinformatics (2006) 1.28
Biomedical negation scope detection with conditional random fields. J Am Med Inform Assoc (2010) 1.27
Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics (2010) 1.27